Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Artiva Biotherapeutics Inc (ARTV)

Artiva Biotherapeutics Inc (ARTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Artiva Biotherapeutics Inc 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121 USA

www.artivabio.com Employees: 89 P: 858-267-4467

Sector:

Medical

Description:

Artiva Biotherapeutics Inc. is a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with devastating autoimmune diseases and cancers. The company's lead program includes AlloNK(R). Artiva Biotherapeutics Inc. is based in SAN DIEGO.

Key Statistics

Overview:

Market Capitalization, $K 104,807
Enterprise Value, $K 64,567
Shares Outstanding, K 24,545
Annual Sales, $ 250 K
Annual Net Income, $ -65,370 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -21,530 K
EBIT, $ -86,150 K
EBITDA, $ -83,720 K
60-Month Beta 3.10
% of Insider Shareholders 21.40%
Float, K 19,292
% Float 78.60%
Short Interest 160
Short Float 0.65%
Short Volume Ratio 0.32

Growth:

1-Year Return -60.77%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.88 on 11/12/25
Next Earnings Date 03/23/26
Earnings Per Share ttm -2.58
EPS Growth vs. Prev Qtr -1.15%
EPS Growth vs. Prev Year 4.35%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ARTV Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -49.99%
Return-on-Assets % -44.05%
Profit Margin % -26,148.00%
Debt/Equity 0.00
Price/Sales 436.14
Price/Cash Flow N/A
Price/Book 0.84
Book Value/Share 5.29
Interest Coverage -2.80
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar